Vanguard Group’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.28M | Sell |
|
|||||
|
2025
Q1 | $2.37M | Buy |
|
|||||
|
2024
Q4 | $3.24M | Sell |
|
|||||
|
2024
Q3 | $3.4M | Sell |
|
|||||
|
2024
Q2 | $3.7M | Sell |
|
|||||
|
2024
Q1 | $4.17M | Buy |
|
|||||
|
2023
Q4 | $7.46M | Buy |
|
|||||
|
2023
Q3 | $12.5M | Buy |
|
|||||
|
2023
Q2 | $12.7M | Buy |
|
|||||
|
2023
Q1 | $9.37M | Sell |
|
|||||
|
2022
Q4 | $24M | Sell |
|
|||||
|
2022
Q3 | $40.9M | Buy |
|
|||||
|
2022
Q2 | $47.8M | Buy |
|
|||||
|
2022
Q1 | $57M | Buy |
|
|||||
|
2021
Q4 | $61.2M | Sell |
|
|||||
|
2021
Q3 | $79.1M | Buy |
|
|||||
|
2021
Q2 | $76.6M | Buy |
|
|||||
|
2021
Q1 | $39M | Buy |
|
|||||
|
2020
Q4 | $71.3M | Buy |
|
|||||
|
2020
Q3 | $710K | Buy |
|